Thomas Kukar, PhD Linkedin Twitter Google Our lab studies the pathogenesis of neurodegenerative diseases to guide development of novel therapeutics. We focus on Frontotemporal dementia (FTD), Amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease (AD). The goal of my laboratory is to develop new strategies to treat neurodegenerative diseases. We aim to understand the pathogenesis of these diseases by […]
Hu Li, PhD Linkedin Dr. Li’s team are focused on systems biology, systems pharmacology and individualized systems medicine. Li’s team is active in developing novel network tools and harnessing machine learning methods to study context-dependent activities of regulatory networks at genome-wide scale. The major theme in the research team is to develop novel computational methods
John (Keoni) Kauwe, PhD Linkedin Twitter Facebook Google John S.K. Kauwe III is the eleventh president of Brigham Young University–Hawaii. He assumed the presidency in July 2020. He was sustained as an Area Seventy on April 4, 2024, and continues to serve in that role today. He is a professor of Biology at Brigham Young
Salvatore Oddo, PhD Linkedin Google Dr. Oddo received his undergraduate degree in Molecular Biology from the University of Catania, Italy, and his graduate degree in Neurobiology of Learning and Memory from the University of California, Irvine. Dr. Oddo’s research focuses on understanding the molecular mechanisms underlying memory deficits in Alzheimer’s disease. Using animal models, he
Molly Zimmerman, PhD Linkedin Twitter Google Dr. Zimmerman is the director of the Neuropsychology Laboratory. She is a licensed clinical neuropsychologist who enjoys engaging in a wide-range of research, teaching, and clinical practice activities. Her research interests explore the many ways in which cognitive abilities interact with medical conditions such as insomnia, sleep apnea, dementia,
Tomohiro Nakamura, PhD Linkedin Our group is focused on a nitric oxide (NO)-mediated posttranslational modification called S-nitrosylation, whereby an NO group reacts with a critical cysteine thiol of a specific protein to regulate its function, akin to the effect of phosphorylation. Excessive generation of NO in the nervous system may constitute a fundamental pathological process
Robert Rissman, PhD Linkedin Google My research at UCSD is split into several parts that I balance relatively equally. The goal of my basic science research is on novel biomarker discovery in Alzheimer’s Disease (AD) and preclinical studies in experimental neuropathology, focused primarily on Alzheimer’s disease. A major focus of my lab in AD biomarkers
Karin Schon, PhD Linkedin Google Dr. Schon is the director of the Brain Plasticity and Neuroimaging Laboratory. She also holds appointments with the Department of Psychological and Brain Sciences, the Center for Memory and Brain, and the Undergraduate and Graduate Programs in Neuroscience. She received her Ph.D. in 2005 and did her postdoctoral research with Prof. Chantal Stern at
